Product
GWP42006
Aliases
Cannabidivarin, CBDV
3 clinical trials
2 indications
Indication
EpilepsyIndication
Focal SeizuresClinical trial
A Randomised, Double-Blind, Placebo-Controlled, Dose Escalation, Safety, Tolerability and Pharmacokinetics Study of Single Ascending and Multiple Doses of GWP42006 in Healthy VolunteersStatus: Completed, Estimated PCD: 2013-12-01
Clinical trial
A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.Status: Completed, Estimated PCD: 2017-07-01
Clinical trial
A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.Status: Completed, Estimated PCD: 2015-10-01